Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| endothelial cell | 20 studies | 27% ± 13% | |
| capillary endothelial cell | 8 studies | 25% ± 5% | |
| endothelial cell of vascular tree | 8 studies | 27% ± 12% | |
| CD16-positive, CD56-dim natural killer cell, human | 7 studies | 26% ± 7% | |
| natural killer cell | 6 studies | 19% ± 3% | |
| cardiac muscle cell | 5 studies | 18% ± 2% | |
| fibroblast | 4 studies | 22% ± 11% | |
| endothelial cell of artery | 4 studies | 26% ± 6% | |
| vein endothelial cell | 4 studies | 29% ± 9% | |
| endothelial cell of lymphatic vessel | 3 studies | 19% ± 2% | |
| smooth muscle cell | 3 studies | 17% ± 0% | |
| neutrophil | 3 studies | 22% ± 6% | |
| classical monocyte | 3 studies | 24% ± 5% | |
| glomerular endothelial cell | 3 studies | 45% ± 12% | |
| mucosal invariant T cell | 3 studies | 22% ± 4% | |
| myeloid cell | 3 studies | 25% ± 5% | |
| squamous epithelial cell | 3 studies | 23% ± 7% | |
| CD8-positive, alpha-beta memory T cell | 3 studies | 18% ± 2% |
Insufficient scRNA-seq data for expression of ITPRIP at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 5838.19 | 1441 / 1445 | 99% | 29.96 | 182 / 183 |
| thymus | 99% | 4539.76 | 647 / 653 | 98% | 22.76 | 595 / 605 |
| uterus | 99% | 3829.18 | 169 / 170 | 97% | 23.59 | 443 / 459 |
| lung | 100% | 8040.54 | 578 / 578 | 95% | 15.63 | 1099 / 1155 |
| breast | 99% | 5321.54 | 455 / 459 | 94% | 12.92 | 1056 / 1118 |
| skin | 100% | 10902.60 | 1809 / 1809 | 93% | 19.33 | 441 / 472 |
| ovary | 99% | 5518.15 | 179 / 180 | 93% | 10.92 | 400 / 430 |
| adrenal gland | 95% | 2642.60 | 245 / 258 | 93% | 17.13 | 215 / 230 |
| kidney | 91% | 3298.04 | 81 / 89 | 97% | 28.96 | 873 / 901 |
| prostate | 93% | 2802.13 | 229 / 245 | 93% | 11.27 | 469 / 502 |
| bladder | 90% | 2813.00 | 19 / 21 | 90% | 13.15 | 454 / 504 |
| intestine | 75% | 1993.67 | 727 / 966 | 93% | 12.11 | 489 / 527 |
| stomach | 72% | 1788.13 | 260 / 359 | 91% | 11.47 | 261 / 286 |
| pancreas | 4% | 59.05 | 13 / 328 | 96% | 19.20 | 171 / 178 |
| adipose | 100% | 7219.90 | 1203 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 7110.54 | 1333 / 1335 | 0% | 0 | 0 / 0 |
| spleen | 100% | 2541.61 | 240 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 98% | 24.39 | 44 / 45 |
| lymph node | 0% | 0 | 0 / 0 | 97% | 11.88 | 28 / 29 |
| heart | 95% | 7227.10 | 821 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 95% | 14.10 | 76 / 80 |
| peripheral blood | 92% | 8950.30 | 853 / 929 | 0% | 0 | 0 / 0 |
| brain | 3% | 63.00 | 92 / 2642 | 85% | 8.59 | 597 / 705 |
| liver | 22% | 425.08 | 49 / 226 | 53% | 4.40 | 215 / 406 |
| muscle | 35% | 695.11 | 278 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_1902042 | Biological process | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors |
| GO_0008625 | Biological process | extrinsic apoptotic signaling pathway via death domain receptors |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0005640 | Cellular component | nuclear outer membrane |
| GO_0016020 | Cellular component | membrane |
| GO_0004860 | Molecular function | protein kinase inhibitor activity |
| GO_0005515 | Molecular function | protein binding |
| Gene name | ITPRIP |
| Protein name | Inositol 1,4,5-trisphosphate receptor interacting protein Inositol 1,4,5-trisphosphate receptor-interacting protein (Protein DANGER) |
| Synonyms | KIAA1754 DANGER |
| Description | FUNCTION: Enhances Ca(2+)-mediated inhibition of inositol 1,4,5-triphosphate receptor (ITPR) Ca(2+) release. . |
| Accessions | ENST00000458723.1 ENST00000278071.6 ENST00000647721.1 Q8IWB1 X6RK76 ENST00000337478.3 ENST00000358187.2 |